Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23482779)

1.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy as salvage treatment for a late wound recurrence of endometrial cancer.

Santeufemia DA, Lumachi F, Basso SM, Tumolo S, Re GL, Capobianco G, Bertozzi S, Pasqual EM.

Anticancer Res. 2013 Mar;33(3):1041-4.

PMID:
23482779
2.

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

Fagotti A, Petrillo M, Costantini B, Fanfani F, Gallotta V, Chiantera V, Turco LC, Bottoni C, Scambia G.

Gynecol Oncol. 2014 Feb;132(2):303-6. doi: 10.1016/j.ygyno.2013.12.028. Epub 2013 Dec 27.

PMID:
24378877
3.

(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Pfannenberg C, Königsrainer I, Aschoff P, Oksüz MO, Zieker D, Beckert S, Symons S, Nieselt K, Glatzle J, Weyhern CV, Brücher BL, Claussen CD, Königsrainer A.

Ann Surg Oncol. 2009 May;16(5):1295-303. doi: 10.1245/s10434-009-0387-7. Epub 2009 Feb 28.

PMID:
19252950
4.

Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.

Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD.

Int J Gynecol Cancer. 2012 Jun;22(5):778-85. doi: 10.1097/IGC.0b013e31824d836c.

PMID:
22572845
5.

Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity.

Helm CW, Toler CR, Martin RS 3rd, Gordinier ME, Parker LP, Metzinger DS, Edwards RP.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):204-9.

PMID:
17291254
6.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of recurrent endometrial carcinoma confined to the peritoneal cavity.

Bakrin N, Cotte E, Sayag-Beaujard A, Raudrant D, Isaac S, Mohamed F, Gilly FN, Glehen O.

Int J Gynecol Cancer. 2010 Jul;20(5):809-14.

PMID:
20973274
7.

Laparotomy wound recurrence of endometrial carcinoma.

Macias V, Baiotto B, Pardo J, Muñoz F, Gabriele P.

Gynecol Oncol. 2003 Nov;91(2):429-34. Review.

PMID:
14599879
8.

Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence.

Sharma P, Kumar R, Singh H, Jeph S, Sharma DN, Bal C, Malhotra A.

Clin Nucl Med. 2012 Jul;37(7):649-55. doi: 10.1097/RLU.0b013e31824d24fa.

PMID:
22691505
9.
10.

18F-FDG PET in the management of endometrial cancer.

Chao A, Chang TC, Ng KK, Hsueh S, Huang HJ, Chou HH, Tsai CS, Yen TC, Wu TI, Lai CH.

Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):36-44. Epub 2005 Sep 16.

PMID:
16167154
11.

Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.

Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1145-53.

PMID:
11483323
12.

Unusual cases: melanomatosis and nephroblastomatosis treated with hyperthermic intraperitoneal chemotherapy.

Hayes-Jordan A, Green H, Prieto V, Wolff JE.

J Pediatr Surg. 2012 Apr;47(4):782-7. doi: 10.1016/j.jpedsurg.2011.12.018.

PMID:
22498396
13.

Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.

Yao M, Graham MM, Smith RB, Dornfeld KJ, Skwarchuk M, Hoffman HT, Funk GF, Graham SM, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1410-8.

PMID:
15590172
14.
15.

The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.

Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB.

Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1081-8. doi: 10.1007/s00259-007-0687-8. Epub 2008 Jan 8.

PMID:
18180917
16.

Double laparotomy wound recurrence of endometrial carcinoma.

Balbi GC, Cardone A, Monteverde A, Passaro M, Montone L, Rossiello R, Visconti S, Battista M, Cassese E, Landino I.

Eur J Gynaecol Oncol. 2006;27(3):307-9. Erratum in: Eur J Gynaecol Oncol. 2006;27(4):320. Battisti, M [corrected to Battista, M].

PMID:
16800268
17.

Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.

Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, Sironi S, Messa C.

Gynecol Oncol. 2009 Nov;115(2):231-5. doi: 10.1016/j.ygyno.2009.07.020. Epub 2009 Aug 19.

PMID:
19695685
18.

Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.

Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.

Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716.

PMID:
22334135
19.

Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.

Kara T, Kara PO, Gedik GK, Sari O.

Rev Esp Med Nucl Imagen Mol. 2012 Jan-Feb;31(1):31-3. doi: 10.1016/j.remn.2011.04.005. Epub 2011 Jul 6.

PMID:
21737185
20.

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.

Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.

PMID:
18521686
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk